NARS2 and Hearing impairment: Patients with biallelic NARS2 mutations usually had bilateral sensorineural hearing impairments (75%, 15/20) in early life (first 3 months), followed by different types of seizures (95.6%, 22/23) within 1 year of age, mainly status epilepticus.